Immunology

Alladapt Immunotherapeutics

Clinical-stage company developing novel oral immunotherapies for treatment of a broad spectrum of food allergies.

Red Tree Participation
Co-investor in Series D

Red Tree Board Observer

Heath Lukatch, Ph.D.

Affiliated with Red Tree SAB Member

Total Addressable Market

$20 billion+

Red Tree Board Member(s)

Red Tree Board Observer

Heath Lukatch, Ph.D.

Affiliated with Red Tree SAB Member

Red Tree Participation
Co-investor in Series D

Alladapt Immunotherapeutics

Immunology
Total Addressable Market

$20 billion+

Red Tree Board Member(s)

Red Tree Board Observer

Heath Lukatch, Ph.D.

Affiliated with Red Tree SAB Member

Red Tree Participation
Co-investor in Series D